Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Contour Health vs NexLife

Contour Health
Graded #186

Lower grade

vs+1.9000000000000057
NexLife
Graded #147

Higher grade

The verdict

NexLife takes it — 68.5/100 to 66.6/100, but only just.

NexLife grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NexLife is a LegitScript-certified telehealth platform offering compounded semaglutide (from $145/mo) and compounded tirzepatide (from $186/mo). Contour Health is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNexLife +6
64
70
Dose & formulationEven
64
64
Clinical oversightNexLife +4
85
89
Labs & monitoringEven
53
53
FulfillmentContour Health +3
70
67
Contract termsEven
55
55
Contour Health · left barNexLife · right bar

The numbers

MetricContour HealthNexLife
WeighScore66.6/10068.5/100
GradeCC
Scorecard rank#186#147
Semaglutide$160/mo (starting dose, compounded)$165/mo (compounded)
Tirzepatide$300/mo (starting dose, compounded)$215/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Contour Health

Graded #186 · C

Strengths

  • Free medical consultation — no charge to talk with a provider before starting
  • Pay-per-vial pricing with no long-term subscription commitment required to participate
  • Names its compounding pharmacy partner (Strive Pharmacy, 503A accredited) — a real transparency signal
  • LegitScript badge links to a genuine, working LegitScript verification checker for the domain
  • Board-certified Medical Director and named nurse-practitioner care team, not anonymous providers

Where it loses points

  • State availability list is not published — Terms of Service only says "certain states"
  • All product purchases are non-refundable per Terms of Service
  • Compounded injectable only — no oral option, no brand-name Wegovy/Zepbound/Ozempic/Mounjaro
  • Terms of Service also describe an optional subscription tier with a 3-month minimum, despite marketing emphasizing "no subscriptions"
  • No insurance, Medicare, or Medicaid accepted — cash-pay or HSA/FSA only
NexLife

Graded #147 · C

Strengths

  • LegitScript certified platform
  • Works exclusively with LegitScript-certified, NABP-accredited pharmacies — strongest pharmacy trust signal in the dataset
  • Both semaglutide and tirzepatide at competitive pricing
  • Semaglutide from $145/mo on the 12-month plan ($165/mo month-to-month) - among the lowest in the dataset

Where it loses points

  • State availability not publicly disclosed
  • Compounded only — no brand-name options
  • Also covers hormone optimization and longevity
  • Lowest advertised rates ($145 sema / $186 tirz) require a 12-month plan commitment

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard